SCYNEXIS Stock

SCYNEXIS P/B

The P/B (Price-to-Book Ratio) of SCYNEXIS (SCYX) as of Jul 14, 2026 is 0.57. In the previous year, P/B (Price-to-Book Ratio) was 0.43 — a change of 32.47% (higher).

P/B

0.57

YoY

32.47%

Last updated:

P/B (Price-to-Book Ratio) of SCYNEXIS is 2026 0.57 . P/B (Price-to-Book Ratio) of SCYNEXIS was 2025 0.43 . It decreases by 32.47% higher compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

P/B (Price-to-Book Ratio) of SCYNEXIS is 0.57 in 2026.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS